StockData
Clene Inc. logo

Clene Inc. (CLNN) stock

CLNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30
$3.22−0.44 (-12.02%)

Close on Nov 17, 2026Market cap $41.37MP/E –Yield –

Clene price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Clene's price to sales ratio was 272.1× on Nov 11, 2026, against 199.3× a year earlier. Over the last 5 years it ranged from 47.1× to 494.8×, with a median of 169.6×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 2026272.1×−8.2
2025Dec 31, 2025280.3×+193.8
2024Dec 31, 202486.5×+5.0
2023Dec 29, 202381.4×−88.1
2022Dec 30, 2022169.6×−291.4
2021Dec 31, 2021461.0×–

More Clene figures

See a number that looks wrong?